Deborah Quinn
2016
In 2016, Deborah Quinn earned a total compensation of $457.3K as Chief Medical Officer at Bellerophon Therapeutics, a 17% decrease compared to previous year.
Compensation breakdown
| Bonus | $120,000 |
|---|---|
| Option Awards | $10,550 |
| Salary | $311,538 |
| Other | $15,208 |
| Total | $457,296 |
Quinn received $311.5K in salary, accounting for 68% of the total pay in 2016.
Quinn also received $120K in bonus, $10.6K in option awards and $15.2K in other compensation.
Rankings
In 2016, Deborah Quinn's compensation ranked 11,489th out of 14,075 executives tracked by ExecPay. In other words, Quinn earned more than 18.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,489 out of 14,075 | 18th |
Division Manufacturing | 4,473 out of 5,486 | 19th |
Major group Chemicals And Allied Products | 1,608 out of 1,900 | 15th |
Industry group Drugs | 1,303 out of 1,543 | 16th |
Industry Pharmaceutical Preparations | 1,007 out of 1,173 | 14th |
Source: SEC filing on March 20, 2017.
Quinn's colleagues
We found three more compensation records of executives who worked with Deborah Quinn at Bellerophon Therapeutics in 2016.